Your browser doesn't support javascript.
loading
Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.
Jiang, Simon H; Mercan, Sevcan; Papa, Ilenia; Moldovan, Max; Walters, Giles D; Koina, Mark; Fadia, Mitali; Stanley, Maurice; Lea-Henry, Tom; Cook, Amelia; Ellyard, Julia; McMorran, Brendan; Sundaram, Madhivanan; Thomson, Russell; Canete, Pablo F; Hoy, Wendy; Hutton, Holly; Srivastava, Monika; McKeon, Kathryn; de la Rúa Figueroa, Iñigo; Cervera, Ricard; Faria, Raquel; D'Alfonso, Sandra; Gatto, Mariele; Athanasopoulos, Vicki; Field, Matthew; Mathews, John; Cho, Eun; Andrews, Thomas D; Kitching, A Richard; Cook, Matthew C; Riquelme, Marta Alarcon; Bahlo, Melanie; Vinuesa, Carola G.
Afiliação
  • Jiang SH; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Mercan S; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Australian National University, Canberra 2601, Australia.
  • Papa I; Department of Renal Medicine, The Canberra Hospital, Canberra 2605, Australia.
  • Moldovan M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Walters GD; Department of Bioengineering, Kafkas University, Kars 36100, Turkey.
  • Koina M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Fadia M; Centre for Population Health Research, University of South Australia, South Australian Health and Medical Research Institute (SAHMRI), Adelaide 5001, Australia.
  • Stanley M; Australian Institute of Health Innovation, Macquarie University, Sydney 2109, Australia.
  • Lea-Henry T; Department of Renal Medicine, The Canberra Hospital, Canberra 2605, Australia.
  • Cook A; Department of Pathology, The Canberra Hospital, Canberra 2605, Australia.
  • Ellyard J; Department of Pathology, The Canberra Hospital, Canberra 2605, Australia.
  • McMorran B; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Sundaram M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Thomson R; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Canete PF; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Hoy W; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Australian National University, Canberra 2601, Australia.
  • Hutton H; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Srivastava M; Department of Renal Medicine, Royal Darwin Hospital, Northern Territory 0811, Australia.
  • McKeon K; Centre for Research in Mathematics and Data Science, School of Computer, Data and Mathematical Sciences, Western Sydney University, Parramatta 2150, NSW, Australia.
  • de la Rúa Figueroa I; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Cervera R; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Australian National University, Canberra 2601, Australia.
  • Faria R; Centre for Chronic Disease, Faculty of Health, The University of Queensland, Brisbane 4029, QLD, Australia.
  • D'Alfonso S; Centre for Inflammatory Diseases, Monash University, Melbourne 3168, VIC, Australia.
  • Gatto M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Athanasopoulos V; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Field M; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Australian National University, Canberra 2601, Australia.
  • Mathews J; University Hospital of Gran Canaria Dr. Negrin, Las Palmas 35010, Spain.
  • Cho E; Department of Autoimmune Diseases, Hospital Clinic, Barcelona 08036, Spain.
  • Andrews TD; Unidade de Imunologia Clinica, Centro Hospitalar Unisersitario do Porto, Porto 4099-001, Portugal.
  • Kitching AR; Amedeo Avogadro University of East Piedmont 13100, Italy.
  • Cook MC; Department of Rheumatology, University of Padova, Italy.
  • Riquelme MA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Canberra, Australian National University, Canberra 2601, Australia.
  • Bahlo M; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Australian National University, Canberra 2601, Australia.
  • Vinuesa CG; Australian Institute of Tropical Health and Medicine, James Cook University, Cairns 4870, QLD, Australia.
Cell Rep Med ; 2(12): 100475, 2021 12 21.
Article em En | MEDLINE | ID: mdl-35028616
ABSTRACT
We identify an intronic deletion in VANGL1 that predisposes to renal injury in high risk populations through a kidney-intrinsic process. Half of all SLE patients develop nephritis, yet the predisposing mechanisms to kidney damage remain poorly understood. There is limited evidence of genetic contribution to specific organ involvement in SLE.1,2 We identify a large deletion in intron 7 of Van Gogh Like 1 (VANGL1), which associates with nephritis in SLE patients. The same deletion occurs at increased frequency in an indigenous population (Tiwi Islanders) with 10-fold higher rates of kidney disease compared with non-indigenous populations. Vangl1 hemizygosity in mice results in spontaneous IgA and IgG deposition within the glomerular mesangium in the absence of autoimmune nephritis. Serum transfer into B cell-deficient Vangl1+/- mice results in mesangial IgG deposition indicating that Ig deposits occur in a kidney-intrinsic fashion in the absence of Vangl1. These results suggest that Vangl1 acts in the kidney to prevent Ig deposits and its deficiency may trigger nephritis in individuals with SLE.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Transporte / Deleção de Genes / Nefropatias / Proteínas de Membrana / Anticorpos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Transporte / Deleção de Genes / Nefropatias / Proteínas de Membrana / Anticorpos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália